Catalog No.
PHN34801
Species reactivity
Human
Host species
Rabbit
Isotype
IgG
Clonality
Polyclonal
Immunogen
E. coli - derived recombinant Human SAE1 (Met1-Lys346).
Target
SAE1, AOS1, Ubiquitin-like 1-activating enzyme E1A, SUA1, SUMO-activating enzyme subunit 1, UBLE1A
Purification
Purified by antigen affinity column.
Accession
Q9UBE0
Applications
ELISA, IHC, WB
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Predictive value of myositis antibodies: role of semiquantitative classification and positivity for more than one autoantibody., PMID:39837620
Clinical features of anti-SAE1 antibody-positive myositis and interstitial lung disease: a multicenter, retrospective study in Taiwan., PMID:39575249
Juvenile dermatomyositis with Anti-SAE antibodies in a Moroccan child associated with pseudo-angioedema: a case report., PMID:38773611
Case report: A case of resistant anti-SAE1 dermatomyositis with severe periorbital edema after hydroxychloroquine that responded to adalimumab., PMID:38501604
Panniculitis on the trunk as a possible characteristic feature of anti-SAE1/2 antibody-positive dermatomyositis: A possible cutaneous manifestation of treatment resistance., PMID:38362647
Detection of Myositis Autoantibodies by Multi-Analytic Immunoassays in a Large Multicenter Cohort of Patients with Definite Idiopathic Inflammatory Myopathies., PMID:37835823
A case of anti-SAE1/2 antibody-positive dermatomyositis with extensive panniculitis: A possible cutaneous manifestation of treatment resistance., PMID:37830399
Trichoscopic, oral, and periungual fold findings as activity and damage markers in dermatomyositis patients and their correlation with myositis antibodies., PMID:36757439
Impaired muscle strength is associated with ultrastructure damage in myositis., PMID:36271295
Two clusters of systemic lupus erythematosus patients with muscle involvement in a Chinese cohort., PMID:36117395
Profile of specific and associated autoantibodies in patients with idiopathic inflammatory myopathies in a Colombian population., PMID:36045923
Cessation of Immunomodulatory Medication Use in Dermatomyositis: A Single-Center Cohort Study., PMID:35792485
Clinical and Autoantibody Associations in Antinuclear Antibody-Positive Systemic Sclerosis Lacking Prototypic Autoantibodies., PMID:35767831
Myositis-specific autoantibodies in clinical practice: Improving the performance of the immunodot., PMID:35427882
A Case of Anti-SAE1 Dermatomyositis., PMID:35280599
The Association of Myositis Specific Antibodies in Patients with Inflammatory Myositis: Preliminary Data in Indian Patients., PMID:34728950
Infliximab in a patient with treatment-resistant anti-SAE dermatomyositis., PMID:33221923
Frequencies and clinical associations of myositis-related antibodies in The Netherlands: A one-year survey of all Dutch patients., PMID:32743501
Extended myositis-specific and -associated antibodies profile in systemic sclerosis: A cross-sectional study., PMID:32653653
Analysis of myositis autoantibodies in Chinese patients with cancer-associated myositis., PMID:32222002
[Dermatomyositis: new antibody, new classification]., PMID:31859626
Distinct dermatomyositis populations are detected with different autoantibody assay platforms., PMID:31376258
SAE1 promotes human glioma progression through activating AKT SUMOylation-mediated signaling pathways., PMID:31345225
Diffuse pruritic erythema as a clinical manifestation in anti-SAE antibody-associated dermatomyositis: a case report and literature review., PMID:31030362
The spectrum and clinical significance of myositis-specific autoantibodies in Chinese patients with idiopathic inflammatory myopathies., PMID:30863950
Evaluating the diagnostic utility of new line immunoassays for myositis antibodies in clinical practice: a retrospective study., PMID:30840145
[Retrospective analysis of anti-TIF1gamma, anti-NXP2 and anti-SAE1/2 antibodies carriers at Bordeaux university hospital from November 2014 to February 2017]., PMID:30527961
Association Between Autoantibody Phenotype and Cutaneous Adverse Reactions to Hydroxychloroquine in Dermatomyositis., PMID:30140893
Anti-SAE Antibody-Positive Dermatomyositis in a Japanese Patient: A Case Report and Review of the Literature., PMID:30074913
Clinical significance of autoantibodies in dermatomyositis and systemic sclerosis., PMID:30047434
Diffuse erythema with 'angel wings' sign in Japanese patients with anti-small ubiquitin-like modifier activating enzyme antibody-associated dermatomyositis., PMID:30022478
Antibodies to small ubiquitin-like modifier activating enzyme are associated with a diagnosis of dermatomyositis: results from an unselected cohort., PMID:29845587
Dermatomyositis Clinical and Pathological Phenotypes Associated with Myositis-Specific Autoantibodies., PMID:29637414
[Dermatomyositis and Autoantibodies]., PMID:29632290
Prevalence of Myositis-Specific Antibodies in Idiopathic Interstitial Pneumonias., PMID:29532165
In Vitro SUMOylation Assay to Study SUMO E3 Ligase Activity., PMID:29443041
Identification of multiple cancer-associated myositis-specific autoantibodies in idiopathic inflammatory myopathies: a large longitudinal cohort study., PMID:29178913
Specific autoantibodies in dermatomyositis: a helpful tool to classify different clinical subsets., PMID:27928683
Interstitial lung disease in an adult patient with dermatomyositis and anti-NXP2 autoantibody., PMID:26028648
Anti-SAE antibodies in autoimmune myositis: identification by unlabelled protein immunoprecipitation in an Italian patient cohort., PMID:22884621
For research use only. Not for human or drug use.
